Comparing traditional and AI-enhanced strategies for developing patient decision aids: a multiple case study.

IF 10.8 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Anik Giguere, Delphine Auclair-Rochon, Maéva Robin, Lidiya Augustine, Julie Ayre, Kirsten McCaffery
{"title":"Comparing traditional and AI-enhanced strategies for developing patient decision aids: a multiple case study.","authors":"Anik Giguere, Delphine Auclair-Rochon, Maéva Robin, Lidiya Augustine, Julie Ayre, Kirsten McCaffery","doi":"10.1136/bmjebm-2025-113675","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Our objective was to develop and test prompts designed to generate balanced, evidence-based information from artificial intelligence (AI) for the development of patient decision aid (DA) content. We compared the outputs of this AI-enhanced strategy with those produced by an experienced human team using a traditional development approach.</p><p><strong>Methods: </strong>We conducted a comparative, mixed-methods, multiple-case study, with each case being a DA. Eight DAs were randomly selected from the Ottawa Inventory, stratified by author type (commercial, academic, public institution, professional association). We then followed a systematic process involving two researchers working independently. One researcher described the topics of the selected DAs and extracted their content by listing the available options with their benefits and harms. The other researcher-blind to the DA-used the topic description to generate AI-enhanced DA content by iteratively refining the prompt structures based on the International Patient Decision Aids Standards until the generated content stabilised. Quantitative analyses compared the number of options, benefits and harms generated by the traditional and AI-enhanced strategies, while qualitative analyses examined the differences in content.</p><p><strong>Results: </strong>The selected DAs targeted different populations (older adults, women, the general population, children) and were produced in Canada, the UK, the USA or Australia. One type of DA (n=6) focused on a specific option (eg, whether to get vaccinated against COVID-19), the other (n=2) focused on improving an outcome (eg, treating attention-deficit/hyperactivity disorder symptoms). For option-focused DAs, 66% of the benefits/harms were generated by the AI-enhanced strategy only and 6.2% by the traditional strategy only. For outcome-focused DAs, 47% of the options were generated by the AI-enhanced strategy only, and 4% by the traditional strategy only. An evidence search confirmed that the options generated only by the AI-enhanced strategy were indeed beneficial, ruling out hallucinations. However, the AI-enhanced strategy did not suggest optimal combinations. Qualitative analysis showed that AI-enhanced content was generally richer.</p><p><strong>Conclusions: </strong>This study provides practical guidance on leveraging AI to improve the efficiency of DA development and improve their quality.</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":"232-241"},"PeriodicalIF":10.8000,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Evidence-Based Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjebm-2025-113675","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Our objective was to develop and test prompts designed to generate balanced, evidence-based information from artificial intelligence (AI) for the development of patient decision aid (DA) content. We compared the outputs of this AI-enhanced strategy with those produced by an experienced human team using a traditional development approach.

Methods: We conducted a comparative, mixed-methods, multiple-case study, with each case being a DA. Eight DAs were randomly selected from the Ottawa Inventory, stratified by author type (commercial, academic, public institution, professional association). We then followed a systematic process involving two researchers working independently. One researcher described the topics of the selected DAs and extracted their content by listing the available options with their benefits and harms. The other researcher-blind to the DA-used the topic description to generate AI-enhanced DA content by iteratively refining the prompt structures based on the International Patient Decision Aids Standards until the generated content stabilised. Quantitative analyses compared the number of options, benefits and harms generated by the traditional and AI-enhanced strategies, while qualitative analyses examined the differences in content.

Results: The selected DAs targeted different populations (older adults, women, the general population, children) and were produced in Canada, the UK, the USA or Australia. One type of DA (n=6) focused on a specific option (eg, whether to get vaccinated against COVID-19), the other (n=2) focused on improving an outcome (eg, treating attention-deficit/hyperactivity disorder symptoms). For option-focused DAs, 66% of the benefits/harms were generated by the AI-enhanced strategy only and 6.2% by the traditional strategy only. For outcome-focused DAs, 47% of the options were generated by the AI-enhanced strategy only, and 4% by the traditional strategy only. An evidence search confirmed that the options generated only by the AI-enhanced strategy were indeed beneficial, ruling out hallucinations. However, the AI-enhanced strategy did not suggest optimal combinations. Qualitative analysis showed that AI-enhanced content was generally richer.

Conclusions: This study provides practical guidance on leveraging AI to improve the efficiency of DA development and improve their quality.

比较传统和人工智能增强的患者决策辅助策略:多案例研究。
目的:我们的目标是开发和测试旨在从人工智能(AI)中生成平衡的、基于证据的信息的提示,用于开发患者决策辅助(DA)内容。我们将这种人工智能增强策略的输出与经验丰富的人类团队使用传统开发方法产生的输出进行了比较。方法:我们进行了一项比较,混合方法,多病例研究,每个病例都是DA。根据作者类型(商业、学术、公共机构、专业协会)随机抽取8份研究报告。然后,我们遵循了一个系统的过程,其中包括两位独立工作的研究人员。一位研究人员描述了所选DAs的主题,并通过列出可用选项及其利弊来提取其内容。另一名对DA一无所知的研究人员使用主题描述来生成ai增强的DA内容,方法是根据国际患者决策辅助标准迭代地改进提示结构,直到生成的内容稳定下来。定量分析比较了传统策略和人工智能增强策略产生的选择数量、收益和危害,而定性分析检查了内容上的差异。结果:选定的DAs针对不同的人群(老年人,妇女,普通人群,儿童),并在加拿大,英国,美国或澳大利亚制作。一种DA (n=6)侧重于特定选择(例如,是否接种COVID-19疫苗),另一种DA (n=2)侧重于改善结果(例如,治疗注意力缺陷/多动障碍症状)。对于侧重于期权的da, 66%的收益/危害仅由人工智能增强策略产生,6.2%仅由传统策略产生。对于以结果为中心的da, 47%的选项仅由人工智能增强策略产生,4%仅由传统策略产生。一项证据搜索证实,仅由人工智能增强策略产生的选项确实是有益的,排除了幻觉的可能性。然而,人工智能增强策略并没有给出最佳组合。定性分析表明,人工智能增强的内容普遍更丰富。结论:本研究为利用人工智能提高数据分析开发效率和质量提供了实践指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Evidence-Based Medicine
BMJ Evidence-Based Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
8.90
自引率
3.40%
发文量
48
期刊介绍: BMJ Evidence-Based Medicine (BMJ EBM) publishes original evidence-based research, insights and opinions on what matters for health care. We focus on the tools, methods, and concepts that are basic and central to practising evidence-based medicine and deliver relevant, trustworthy and impactful evidence. BMJ EBM is a Plan S compliant Transformative Journal and adheres to the highest possible industry standards for editorial policies and publication ethics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书